EN DE
Check 35,000+ stocks against 26 valuation models and 37 quality factors
Data-driven stock valuation

UltraGreen Ai Ltd (ULG) fair value: what the stock is really worth

As of Sep 24, 2026: fair value of UltraGreen Ai Ltd $1.44, price $0.61, upside +138.0%, quality 72 out of 100. Calculated from audited financials with 26 valuation models and 37 quality factors, updated daily.

  1. Fair value above price? Yes
  2. Good quality? Yes
  3. Add to watchlist

Healthcare · SG

UA Thin data Sep 24, 2026

UltraGreen Ai Ltd

ULG · SG

Clearly undervaluedStrong Fair Value upside, but quality is only moderate.

✓Fair value $1.44 · Strongly undervalued (+138%)
✓Quality 72/100
✓Healthy Growth (revenue 3y +41.0 %/yr)
✓Highly profitable · 54.8% net margin (TTM)
✓Low debt · generates free cash flow
✓Ranks above peers (11/14)
✓Wide moat 100/100
!Evidence only low, so the estimate is less certain

What runs behind every stock

69 individual criteria per stock, every one traceable See the method →

Price vs Fair Value

$1.86 $0.5550 Fair Value $1.44 Dec 2025 Sep 2026

White line = price, green steps = our fair value per fiscal year. As of Sep 24, 2026.

How to read this chart

10‑month range $0.5550 – $1.86 · fair‑value band $0.8700 – $2.13 · the $0.6050 price screens below the $1.44 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). As of Sep 24, 2026.

Follow UltraGreen Ai in your weekly email

Every Wednesday you see whether UltraGreen Ai is on track or worth a review, plus price against fair value. Free, up to 3 stocks.

We send you a confirmation link. Unsubscribe with one click.

Which stocks are undervalued right now? Check free Discover now →

Company profile

UltraGreen.ai Limited manufactures and sells Indocyanine Green (ICG) pharmaceutical products in the United States and internationally. It provides diagnostic imaging analytics and software solutions.

Show more

UltraGreen.ai Limited manufactures and sells Indocyanine Green (ICG) pharmaceutical products in the United States and internationally. It provides diagnostic imaging analytics and software solutions. The company also develops software for real-time quantification of blood perfusion during surgery, including PerfusionWorks quantification software for tissue perfusion, lymphatic mapping, and margin assessment. In addition, it offers products, such as ICG, the IC-Flow Imaging System and the UltraGreen Data Platform and other technologies related to fluorescence guided surgery. Further, the company sells ICG vials and related pharmaceutical products; and engages in software development activities. It serves healthcare providers, hospitals, and medical technology companies. The company was formerly known as UltraGreen.ai Private Limited and changed its name to UltraGreen.ai Limited. UltraGreen.ai Limited was incorporated in 2024 and is based in Singapore. UltraGreen.ai Limited operates as a subsidiary of Renew Group Private Limited.

Stock analysis

UltraGreen Ai Ltd (ULG) currently trades at $0.6050, while our model-based Fair Value estimate is $1.44, implying the stock looks roughly 58.0% undervalued today.

Show more

Valuation

Bull case: the Growth Earnings group reads highest at a median of $3.16 per share, and 20 of the 26 models we run sit above the $0.6050 price.

Bear case: the Asset-Based group reads lowest at $0.1900, and 6 of the 26 models stay below the price. Evidence for this calculation is low.

Scenario range: $0.8700 (bear) to $2.13 (bull), the price of $0.6050 sits below it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.

Quality & growth

The Quality Score stands at 72/100 (solid quality), in the Healthcare sector.

Healthy Growth: Revenue growth appears healthy and is supported by profitability and cash-flow quality.

UltraGreen Ai Ltd reported revenue of $138M in FY2025 versus $49.2M in FY2022, a compound +41.0%/yr. Reported net income was $75.6M in FY2025, compounding +47.6%/yr from FY2022.

Key figures

Market cap $1.4B · P/E ratio 9.8 · P/S ratio 5.36 · EPS (TTM) $0.1300 · Dividend yield 2.8% · Net margin 54.8% · Return on equity 35.9% · Return on assets (EBIT) 33.1%.

Competitive moat

Our AI-assisted moat analysis scores the competitive advantage at 50 out of 100 (low confidence).

What moves the price

For context, the median of 10 Healthcare peers we cover trades at −45% fair-value upside, at 138%, ULG screens cheaper than that median.

Fair Value models

Bear $0.8700 Fair Value $1.44 Bull $2.13
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above is their evidence-weighted blend, not the output of a single model. Based on fiscal year 2025 figures (about 9 months old). Earnings retained since then ($0.0955 per share) are deliberately not added. Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. Evidence ⓘEvidence = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Highest evidence
FCF DCF $0.7200 $0.9700 $1.74 75
Growth DCF $0.6800 $1.06 $1.66 74
EPV $0.6400 $0.7000 $0.7600 71
All 26 models by family
DCF Models
FCF DCF $0.7200 $0.9700 $1.74 75
Owner Earnings $1.01 $1.92 $3.61 69
5Y Revenue Exit $0.5300 $0.7600 $1.24 68
5Y EBITDA Exit $0.9300 $1.56 $2.80 69
5Y P/E Exit $1.12 $2.41 $4.18 65
10Y Revenue Exit $0.5900 $0.9900 $1.22 65
10Y EBITDA Exit $0.8600 $1.77 $3.36 62
10Y P/E Exit $0.9900 $2.15 $4.08 57
Earnings-Based
Graham-Dodd $0.4700 $3.25 $4.57 60
Lynch FV $1.66 $2.37 $3.08 58
PEG = 1.0 $1.66 $2.37 $3.08 55
EPV $0.6400 $0.7000 $0.7600 71
Dividend Discount
Gordon GGM $0.2800 $0.5000 $0.6900 65
DDM Multi-Stage $0.2800 $0.4600 $0.5400 64
Multiples
P/E Multiple $1.13 $1.51 $1.89 63
P/S Multiple $0.3300 $0.4400 $0.5500 58
P/B Multiple $0.8700 $1.17 $1.46 55
EV/EBIT $1.12 $1.45 $1.77 66
EV/EBITDA $1.01 $1.30 $1.58 67
EV/Revenue $0.4200 $0.5400 $0.6500 54
Asset-Based
NCAV (Graham) $0.1400 $0.1900 $0.2800 54
Growth DCF
Growth DCF $0.6800 $1.06 $1.66 74
Rev-Margin DCF $0.5700 $0.8500 $1.44 68
Economic Profit
Residual Income $0.3800 $0.4900 $1.60 61
ROIC Compounder $0.7400 $0.9700 $1.24 69
Growth Earnings
Growth-Adj P/E $2.21 $3.16 $4.10 65

Open the full fair value analysis →

Notify me when ULG reaches fair value

Put ULG on your watchlist. We get in touch as soon as price and fair value meet or the trend turns.

Set up alert →

Quality Score breakdown

Overall quality 72/100

Of which business quality 70 · Market factors (momentum, volatility) 0

Profitability 74
Margins and returns on capital today
Quality Growth 40
Are margins and returns improving?
Cashflow 74
Earnings quality: real cash, not paper profit
Fin. Strength 100
Balance sheet, leverage, solvency risk
Investment 26
Disciplined investing over empire-building
Low Volatility 0
Calm price path (market factor)
Momentum 0
Price trend over the last 3–12 months (market factor)
52W Momentum 2
Distance to the 52-week high (market factor)
Net Issuance 82
Share count: buybacks or dilution?

Open the full quality analysis →

Revenue & earnings trend

Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card. 100/100
Revenue growth appears healthy and is supported by profitability and cash-flow quality.
Revenue growth 1 year
+27.7%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+41.0%
What shareholders gained per year (last 3 years) (mathematically smoothed) ⓘWhat the business itself delivers per year: earnings growth per share plus the dividend yield. This is what you get IF the market keeps valuing the stock the same way: it contains no assumption about the market changing its mind. Computed per share, so buybacks count and a merger does not pass as growth. For a company that pays no dividend it is pure earnings growth per share. Period: earnings growth per share as CAGR over the last 3 reported fiscal years (annual statements), plus the current dividend yield. The start value is the median of the three years around the start, so a single crisis year (a pandemic or a write-down) does not distort the rate. Smoothed = median of all growth paths between the years of the window (trend line on the logarithm of earnings per share): a single extreme year cannot distort the rate. The reported figure stays in the tooltip.
+52.2%
Earnings growth per share plus dividend.
Earnings per share, growth per year+49.4%
Dividend (yield on the price)2.8%
Profit margin 2022 to 2025 ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.48% → 61%
2025 sits 129% above its own trend. The rate follows the median trend of the last 3 years, not that single year.

Growth Forecast

Little optimism in the price
The price assumes less growth than the company has delivered so far and less than analysts expect.
What the price assumes ⓘThis turns our valuation around: instead of asking what the share is worth, it asks what growth the current price requires. It uses the cash the company keeps after all spending (free cash flow), the same discount rate as our models, five years of growth, then slowing evenly to 2 % a year by year ten. Compared with the analysts' sales forecasts extended to the same five years (at least three analysts, for context only, it does not enter the Fair Value): within 3 percentage points counts as "in line" (amber), below that little optimism (green), above that a lot of optimism (red).
−5.3%
Yearly growth needed for the next five years to justify today's price.
What forecasts expect ⓘAnalysts publish sales forecasts for the next two fiscal years. For the years after that, growth slows evenly to 2 % a year by year ten (2 % is the long-run rate our models use). Projected years are marked as such.
+17.6%
Yearly sales growth analysts expect, extended to five years.
After inflation (figures in USD, USA: IMF forecast 2.4% a year to 2030, 3.1% from 2016 to 2025) that is about −7.5% a year for the price and +14.9% for the forecasts.
Forecast 2026 (sales)+28.5%
Forecast 2027 (sales)+18.1%
Projected 2028 (sales)+16.1%
Projected 2029 (sales)+14.1%
Projected 2030 (sales)+12.1%

Watch ULG, get fair value alerts →

Compare UltraGreen Ai Ltd with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Health Information Services · 134 stocks

Beats the industry median on 10/13 measures
Overall it ranks above its industry peers.
Valuation
Quality Score 72 · Top 25%
Fair Value upside +132% · Top 25%
Profitability
Return on equity (TTM) 36% · Top 25%
Return on assets 22% · Top 25%
Net margin (TTM) 55% · Top 25%
Operating margin (TTM) 60% · Top 25%
Growth and dividend
Revenue growth 20% · Above median
Dividend yield (TTM) 2.8% · Above median

Valuation Multiplesvs Health Information Services median · lower = cheaper

P/E (TTM) 9.8× · Cheapest 25%
P/B 4.51× · Priciest 25%
P/S (TTM) 10.15× · Priciest 25%
P/FCF 31.0× · Priciest 25%
EV/EBITDA 13.9× · Cheaper than median

Strength profile in five axes (Snowflake)

VALUEFUTUREPASTHEALTHDIVIDEND
This stock
VALUEFUTUREPASTHEALTHDIVIDEND
Sector peers
VALUE (fair-value potential)100 · sector 3
FUTURE (revenue growth)100 · sector 34
PAST (return on equity)100 · sector 5
HEALTH (low debt)100 · sector 98
DIVIDEND (yield)57 · sector 48

Context: sector, industry, market

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

Similar stocks

10 more Health Information Services stocks, each showing price versus our Fair Value estimate.

Stock Price Fair Value vs Fair Value
Veeva Systems Inc VEEV $270.75 $297.83 +10%
Pro Medicus Limited PME A$161.31 A$64.50 −60%
BrightSpring Health Services, Inc BTSG $56.55 $26.07 −54%
HealthEquity, Inc HQY $91.75 $100.93 +10%
Hinge Health, Inc HNGE $94.15 $51.66 −45%
10x Genomics, Inc TXG $80.70 $21.71 −73%
Waystar Holding WAY $25.63 $28.19 +10%
XtalPi Holdings 2228 HK$8.39 HK$1.50 −82%
Doximity, Inc DOCS $26.51 $31.41 +18%
Privia Health Group PRVA $19.46 $5.26 −73%

Explore undervalued stocks

More undervalued Healthcare stocks →

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued High-Quality StocksUndervalued Blue-Chip StocksUndervalued Small-Cap StocksUndervalued Dividend Stocks

Try a ready-made strategy

Pick a strategy and jump into the live analysis with that exact screen applied.

🥇 Backtested Best 🏆 Big Names ⭐ Top Rated 💎 Quality on Sale 🚀 Profitable Growth 🧊 Quality Compounders 💵 Dividend Stars 📈 Strong Momentum 📉 Fallen Angels ⚖️ Deeply Undervalued 🔍 Small-Cap Gems 🏰 Moat at a Fair Price 💼 Insider Buying 🎩 Buffett-Style Quality 📚 Peter Lynch GARP 🧮 Greenblatt Magic Formula 🛡️ Graham Defensive

Discover tools

For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

Cite: Fair Value Calculator (2026). "UltraGreen Ai Ltd Fair Value". https://www.fairvalue-calculator.com/stock/ULG

Frequently asked questions

Is UltraGreen Ai Ltd (ULG) overvalued or undervalued?
As of Sep 24, 2026, our model estimates a fair value of $1.44 versus a price of $0.6050, about +138% upside (undervalued).
What is the fair value of ULG?
Our model-based fair value for UltraGreen Ai Ltd is $1.44 (as of Sep 24, 2026), built from audited fundamentals. The current price: $0.6050.
What is the quality score of ULG?
UltraGreen Ai Ltd has a Quality Score of 72/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for UltraGreen Ai Ltd (ULG)?
Our model-based price target is the fair value of $1.44 (as of Sep 24, 2026) from 26 valuation models. Cautious scenario $0.8700, optimistic scenario $2.13. It is a calculation from audited fundamentals, not an analyst target.
What is the UltraGreen Ai Ltd stock forecast for 2026?
Our models put fair value at $1.44, about +138% upside versus a price of $0.6050 (undervalued). Cautious scenario $0.8700, optimistic scenario $2.13. The calculation is refreshed regularly with new filings.
What is the revenue of UltraGreen Ai Ltd (ULG)?
UltraGreen Ai Ltd reported trailing-twelve-month revenue of about $138M (latest available figure, as of Sep 24, 2026).
Does UltraGreen Ai Ltd pay a dividend?
UltraGreen Ai Ltd currently shows a dividend yield of about 2.84% relative to its recent price (as of Sep 24, 2026).
What growth is priced into UltraGreen Ai Ltd (ULG)?
For today's price to be fair in a discounted-cash-flow model, UltraGreen Ai Ltd would have to grow free cash flow by -5.3 % per year for five years (discount rate 11.0 %, then slowing evenly to 2 % perpetual growth by year ten). Over the last 3 years revenue grew +41.0 % per year. As of Sep 24, 2026.
What discount rate (WACC) does the fair value of ULG use?
Our models discount UltraGreen Ai Ltd at 11.0 %: a base by market capitalisation (small), country premium for Singapore. The same rate applies in all 26 models.
What is a reverse DCF?
A reverse DCF turns the usual calculation around. Instead of deriving a value from assumptions, it takes today's price as given and asks: what free-cash-flow growth would a company have to deliver for exactly this price to be fair? The result is not a forecast but the expectation already priced in. For UltraGreen Ai Ltd that is -5.3 % per year a year over ten years, using the same discount rate (11.0 %) and the same formula as our fair value.
How much growth has UltraGreen Ai Ltd (ULG) delivered so far?
Over the past 3 years revenue at UltraGreen Ai Ltd grew +41.0 % a year. The price currently implies -5.3 % per year free-cash-flow growth a year. Comparing the two shows how much confidence is in the price: if it demands more than has been delivered, the business has to accelerate for the maths to work.
How fast is the sector of UltraGreen Ai Ltd (ULG) growing?
The median revenue growth in the sector is +0.0 % a year. That is the yardstick for the growth priced into UltraGreen Ai Ltd (-5.3 % per year a year): it shows whether the expectation is within the usual range or beyond it.
What is the free cash flow yield of UltraGreen Ai Ltd (ULG)?
The free-cash-flow yield on the price is 8.65 %: that much free cash flow UltraGreen Ai Ltd produces per unit of market value. When it exceeds the discount rate of our models (11.0 %), the business already earns more than its cost of capital demands, and the price needs little additional growth.
What is the intrinsic value of UltraGreen Ai Ltd (ULG)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For UltraGreen Ai Ltd it is $1.44 per share (as of Sep 24, 2026), against a price of $0.6050. It is the blended result of 26 valuation models (cash flow, earnings, asset, dividend).
Is UltraGreen Ai Ltd stock overvalued or undervalued in 2026?
As of Sep 24, 2026, ULG trades below its calculated fair value: price $0.6050, fair value $1.44, a gap of about +138% (undervalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of ULG?
No. The price is what the market pays today ($0.6050); the fair value is what the company's own numbers justify ($1.44). For UltraGreen Ai Ltd the two are $0.8350 per share apart. That gap is exactly why we show both numbers side by side.
How much is UltraGreen Ai Ltd worth?
The market values UltraGreen Ai Ltd at about $1.4B (market capitalisation, as of Sep 24, 2026). Per share that is $0.6050; our models calculate a fair value of $1.44 per share.
What do the bullish and bearish scenarios say about ULG?
Our models span a range for UltraGreen Ai Ltd: cautious scenario $0.8700, base $1.44, optimistic $2.13 per share (as of Sep 24, 2026, price $0.6050). The range comes from different growth and margin assumptions, not from analyst opinions.
What is the P/E ratio of ULG?
UltraGreen Ai Ltd trades at a price-to-earnings ratio of 9.8 (as of Sep 24, 2026). A P/E on its own says little: it compares the price with ONE year of profit, while our fair value of $1.44 is built from several models across several years. Other multiples: P/B 4.5, P/S 10.2, EV/EBITDA 13.9.
How solid is the balance sheet of UltraGreen Ai Ltd (ULG)?
Balance-sheet figures for UltraGreen Ai Ltd (as of Sep 24, 2026): return on equity 35.9%. They feed the Quality Score of 72/100, which measures business quality independently of the share price.
Which stocks are comparable to UltraGreen Ai Ltd?
From the same area (Healthcare) we also value Veeva Systems Inc, Pro Medicus Limited, BrightSpring Health Services, Inc, HealthEquity, Inc, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is UltraGreen Ai Ltd stock attractive at the current price?
The data as of Sep 24, 2026: price $0.6050, calculated fair value $1.44 (+138%), Quality Score 72/100, from 26 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of ULG calculated?
We run UltraGreen Ai Ltd through 26 models from four families: discounted cash flow, earnings models, asset and balance-sheet models, and dividend models. Every model gets the same audited fundamentals; the result is the weighted average of $1.44, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 13.0 % above its aggregate fair value. UltraGreen Ai Ltd currently trades 138 % below its own fair value, and the market average says nothing about that. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of UltraGreen Ai Ltd (ULG)?
The closing price on Sep 24, 2026 was $0.6050. Our model-based fair value is $1.44, about +138% upside (undervalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with UltraGreen Ai Ltd right now?
The rarer combination: high quality (72/100) AND below fair value. That earns a closer look rather than a quick verdict. The price is below even our cautious bear case ($0.8700). The market is more pessimistic than our downside scenario. The large gap to fair value rests on thin data (low evidence): fewer applicable models and a shorter history. Read it with extra caution. A fairly wide model range ($0.8700 to $2.13) leaves room in how you read the outcome.

Key figures of UltraGreen Ai Ltd

How large is the market capitalisation of UltraGreen Ai Ltd (ULG)?
The market capitalisation of UltraGreen Ai Ltd is $1.4B. The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of UltraGreen Ai Ltd (ULG)?
The price-to-sales ratio of UltraGreen Ai Ltd is 5.36 (P/E × margin). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of UltraGreen Ai Ltd (ULG)?
Earnings per share at UltraGreen Ai Ltd are $0.1300 (price ÷ EPS = P/E 9.8). Earnings per share over the last twelve months: total profit spread across every single share.
What is the dividend yield of UltraGreen Ai Ltd (ULG)?
The dividend yield of UltraGreen Ai Ltd is 2.8% (payout 13.2%). Yearly dividend relative to the share price. 3% pays 3 per 100 invested. Below: how much of profit is used for it.
What is the net margin of UltraGreen Ai Ltd (ULG)?
The net margin of UltraGreen Ai Ltd is 54.8% (fiscal year 2025). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of UltraGreen Ai Ltd (ULG)?
The return on equity (ROE) of UltraGreen Ai Ltd is 35.9% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of UltraGreen Ai Ltd (ULG)?
On an EBIT basis the return on assets of UltraGreen Ai Ltd is 33.1% (avg 4y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of UltraGreen Ai Ltd (ULG)?
The operating margin of UltraGreen Ai Ltd is 60.5% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at UltraGreen Ai Ltd (ULG)?
Revenue at UltraGreen Ai Ltd is growing +20.3% versus a year earlier (3y avg +41.0%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at UltraGreen Ai Ltd (ULG)?
Earnings per share at UltraGreen Ai Ltd are growing −7.6% versus a year earlier. How much earnings per share grew versus a year earlier.
How much net debt does UltraGreen Ai Ltd (ULG) carry?
The net debt of UltraGreen Ai Ltd is $9.3M (fiscal year 2024, ≈ 0.2 yrs of FCF). Debt minus cash on hand. The note shows how many years of free cash flow could in theory pay it off.
Free · no account needed

Watch UltraGreen Ai Ltd in the live analysis

One click puts UltraGreen Ai Ltd on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 35,000+ stock screener. You can also try 14 days of Pro there, no card.

Watch for free →

Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.